45
Tempest Therapeutics closes $7.5M raise in Brisbane biotech
Company raise · Closed · Offering $7.5M · Sold $7.5M · BRISBANE, CA · filed 2026-10-14
Placement agent engaged
40
Tempest Therapeutics, Inc. raises $4.1M under Reg D
Company raise · Closed · BRISBANE, CA · Form D filed 2026-06-23
Business combination
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| John David Yee | Director |
| Matthew Angel | President and Chief Executive Officer |
| Justin Trojanowski | Vice President, Finance, Principal Financial Officer and Corporate Secretary |
| William Drake Richey | Director |
Signed by Matthew Angel, President and Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
40
Tempest Therapeutics, Inc. raises $2M under Reg D
Company raise · Closed · Offering $2M · Sold $2M · BRISBANE, CA · filed 2026-04-03